3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neoplasms
1
Myelodysplastic Syndromes
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Prolymphocytic, B-Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Biphenotypic, Acute
1
Kidney Neoplasms
1
Glioma
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Burkitt Lymphoma
1
Interventions
Whole-Body Irradiation
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Methotrexate
3
Cytarabine
3
venetoclax
2
ponatinib
2
merphos
2
fludarabine phosphate
2
Tacrolimus
2
Idarubicin
2
Etoposide
2
Cyclosporine
2
Cyclophosphamide
2
Cladribine
2
Busulfan
2
nilotinib
1
midostaurin
1
gilteritinib
1
bosutinib
1
blinatumomab
1
asciminib
1
Thiotepa
1
Sirolimus
1
Razoxane
1
N,N-dicyclohexyl-isoborneol-10-sulfonamide
1
Melphalan
1
Injections
1
Imatinib Mesylate
1
Gemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Blast Crisis
×
Blood Component Removal
×
30 days
×
Clear all
No trials found.